Neuromuscular Disorders: In Vitro

This feed focuses on experimental systems, including cell and tissue-based therapies, as well as genomic and proteomic approaches, used to study neuromuscular disorders in vitro. Discover the latest research on neuromuscular disorders in vitro here.

December 29, 2020
Open Access

AChRs Degeneration at NMJ in Aging-Associated Sarcopenia-A Systematic Review

Frontiers in Aging Neuroscience
Zhengyuan BaoWing-Hoi Cheung
January 8, 2021
Preprint
Open Access

Compartmentalized three-dimensional human neuromuscular tissue models fabricated on a well-plate-format microdevice

BioRxiv : the Preprint Server for Biology
K. YamamotoKazunori Shimizu
December 29, 2020

Production of Innervated Skeletal Muscle Fibers Using Human Induced Pluripotent Stem Cells

Methods in Molecular Biology
Mégane DelourmeFrédérique Magdinier
December 18, 2020
Open Access

Tissue Engineered Bands of Büngner for Accelerated Motor and Sensory Axonal Outgrowth

Frontiers in Bioengineering and Biotechnology
Kate V PanzerD Kacy Cullen
January 16, 2021

Advances in CNS organoids: a focus on organoid-based models for motor neuron disease

Tissue Engineering. Part C, Methods
Renata Vieira de SaJeroen Pasterkamp
December 19, 2020
Open Access

Variants of CAPN3 cause limb-girdle muscular dystrophy type 2A in two Chinese families

Experimental and Therapeutic Medicine
Jie ZhengChunquan Cai
January 8, 2021
Preprint
Open Access

Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN

BioRxiv : the Preprint Server for Biology
M. NogamiHideyuki Okano
January 6, 2021

Application of Optogenetics for Muscle Cells and Stem Cells

Advances in Experimental Medicine and Biology
Toshifumi AsanoHiromu Yawo
December 29, 2020
Open Access

Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model

PloS One
Alper YavasNicole Datson
December 29, 2020
Open Access

LSM12-EPAC1 defines a neuroprotective pathway that sustains the nucleocytoplasmic RAN gradient

PLoS Biology
Jongbo LeeChunghun Lim
January 8, 2021
Preprint
Open Access

Enhanced detection of nucleotide repeat mRNA with hybridization chain reaction

BioRxiv : the Preprint Server for Biology
M. R. GlineburgPeter Todd
January 12, 2021

Molecular pathophysiology of human MICU1-deficiency

Neuropathology and Applied Neurobiology
Nicolai KohlschmidtAndreas Roos
January 5, 2021

Loss of FEZ1, a gene deleted in Jacobsen syndrome, causes locomotion defects and early mortality by impairing motor neuron development

Human Molecular Genetics
Saravanan GunaseelanJohn Jia En Chua
January 15, 2021
Open Access

Effects of Survival Motor Neuron Protein on Germ Cell Development in Mouse and Human

International Journal of Molecular Sciences
Wei-Fang ChangLi-Ying Sung
January 10, 2021
Open Access

Sulf2a controls Shh-dependent neural fate specification in the developing spinal cord

Scientific Reports
Cathy DanesinCathy Soula
December 8, 2020
Review
Open Access

The Neglected Genes of ALS: Cytoskeletal Dynamics Impact Synaptic Degeneration in ALS

Frontiers in Cellular Neuroscience
María José Castellanos-MontielThomas M Durcan

Sign up to follow this feed and discover related papers.

Related Feeds

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Artificial Cell Models

This feed focuses on biomimetrics, synthetic biology and bio- and tissue-engineering approaches used for modeling human diseases.

© 2021 Meta ULC. All rights reserved
/feed-previews/neuromuscular-disorders-in-vitro/60d14e6a-e0fd-4e9c-8c49-3abfd322698c